Indirect comparison of azacitidine and decitabine for the therapy of elderly patients with acute myeloid leukemia: a systematic review and network meta-analysis

BACKGROUND: The DNA hypomethylating agents (HMAs) decitabine and azacitidine have been widely used in the management of elderly patients with acute myeloid leukemia (AML). However, no direct clinical trials have been carried out to compare the two agents. A systematic review and network meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Bingbing, You, Weiwen, Yang, Sitian, Du, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075015/
https://www.ncbi.nlm.nih.gov/pubmed/32190414
http://dx.doi.org/10.1186/s40164-020-00160-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075015/
https://www.ncbi.nlm.nih.gov/pubmed/32190414
http://dx.doi.org/10.1186/s40164-020-00160-8

Ejemplares similares